Human tissue distribution of paraoxonases 1 and 2 mRNA

IUBMB Life

Volumn 62, Issue 6, 2010, Pages 480-482

  Mackness, Bharti ^a   Beltran Debon, Raul ^a   Aragones, Gerard ^a   Joven, Jorge ^a   Camps, Jordi ^a   Mackness, Mike ^a  

^a HOSPITAL UNIVERSITARI SANT JOAN DE REUS   (Spain)

Author keywords

Human tissues; Inflammation; MRNA; Oxidation; Paraoxonase 1; Paraoxonase 2

Indexed keywords

ARYLDIALKYLPHOSPHATASE 1; ARYLDIALKYLPHOSPHATASE 2; MESSENGER RNA;

ADRENAL GLAND; ARTICLE; BONE MARROW; BRAIN; COLON; FETUS LIVER; GENE EXPRESSION; HEART; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY; LEUKOCYTE; LIVER; LUNG; MISSENSE MUTATION; MUSCLE; PANCREAS; PLACENTA; PROTEIN LOCALIZATION; REAL TIME POLYMERASE CHAIN REACTION; SALIVARY GLAND; SKIN; SMALL INTESTINE; SPLEEN; STOMACH; TESTIS; THYROID GLAND; TISSUE DISTRIBUTION;

ARYLDIALKYLPHOSPHATASE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; RNA, MESSENGER;

EID: 77953553815     PISSN: 15216543     EISSN: 15216551     Source Type: Journal    
DOI: 10.1002/iub.347     Document Type: Article

References (25)

1. Primo-Parma, S. L., Sorenson, R. C., Teiber, J., and La Du, B. N. (1996) The human serum paraoxonase/arylesterase gene (PON1) is one member of a multigene family. Genomics 33, 498-509.
2. Draganov, D. I. and La Du, B. N. (2004) Pharmacogenetics of paraoxonase: a brief review. Naunyn Schmiedebergs Arch. Pharmacol. 369, 78-88.
3. Deakin, S., Leviev, I., Gomaraschi, M., Calabresi, L., Franceschini, G., and James, R. W. (2002) Enzymatically active paraoxonase 1 is located at the external membrane of producing cells and released by a high affinity, saturable, desorption mechanism. J. Biol. Chem. 277, 4301-4308.
4. Furlong, C. E. (2008) Paraoxonase: an historical perspective. In The Paraoxonases: Their Role in Disease Development and Xenobiotics Metabolism. (Mackness, B., Mackness, M., Aviram, M., Paragh, G., eds.). pp. 3-32, Springer, Dordrect.
5. Mackness, M. I., Arrol, S., and Durrington, P. N. (1991) Paraoxonase prevents accumulation of lipoperoxides in low-density lipoprotein. FEBS Lett. 286, 152-154.
6. Draganov, D. I., Teiber, J. F., Speelman, A., Osawa, Y., Sunahara, R., and La Du, B. N. (2005) Human paraoxonases (PON1, PON2 and PON3) are lactonases with overlapping and distinct substrate specificities. J. Lipid Res. 46, 1239-1247.
7. Jakubowski, H. (2000) Calcium-dependent human serum homocysteine thiolactone hydrolase. J. Biol. Chem. 275, 3957-3962.
8. Mackness, M. I., Arrol, S., Abbott, C. A., and Durrington, P. N. (1993) Protection of low-density lipoprotein against oxidative modification by high-density lipoprotein associated paraoxonase. Atherosclerosis 104, 129-135.
9. Aviram, M., Hardak, E., Vaya, J., Mahmood, S., Milo, S., Hoffmann, A., Billicke, S., Draganov, D., and Rosenblat, M. (2000) Human serum paraoxonase (PON1) Q and R selectively decrease lipid peroxides in human coronary and carotid atherosclerotic lesions: PON1 esterase and peroxidase-like activities. Circulation 101, 2510-2517.
10. Watson, A. D., Berliner, J. A., Hama, S. Y., La Du, B. N., Fault, K. F., Fogelman, A. M., and Navab, M. (1995) Protective effect of high density lipoprotein associated paraoxonase-inhibition of the biological activity of minimally oxidised low-density lipoprotein. J. Clin. Invest. 96, 2882-2891.
11. Ng, C. J., Wadleigh, D. J., Gangopadhyay, A., Hama, S., Grijalva, V. R., Navab, M., Fogelman, A. M., and Reddy, S. T. (2001) Paraoxonase- 2 is a ubiquitously expressed protein with antioxidant properties and is capable of preventing cell-mediated oxidative modification of low density lipoprotein. J. Biol. Chem. 276, 4444-4449.
12. Reddy, S. T., Wadleigh, D. J., Grijalva, V., Ng, C., Hama, S., Gangopadhyay, A., Shih, D. M., Lusis, A. J., Navab, M., and Fogelman, A. M. (2001) Human paraoxonase-3 is an HDL-associated enzyme with biological activity similar to paraoxonase-1 protein but is not regulated by oxidised lipids. Arterioscler. Thromb. Vasc. Biol. 21, 542-547.
13. Rodrigo, L., Hernandez, A. F., Lopez-Caballero, J. J., Gil, F., and Pla, A. (2001) Immunohistochemical evidence for the expression and induction of paraoxonase in rat liver, kidney, lung and brain tissue. Implications for its physiological role. Chem. Biol. Interact. 137, 123-137.
14. Mackness, B., Hunt, R., Durrington, P. N., and Mackness, M. I. (1997) Increased immunolocalisation of paraoxonase, clusterin and apolipoprotein AI in the human artery wall with progression of atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 17, 1233-1238.
15. Marsillach, J., Mackness, B., Mackness, M., Riu, F., Beltran, R., Joven, J., and Camps, J. (2008) Immunohistochemical analysis of paraoxonases- 1,2, and 3 expression in normal mouse tissues. Free Radic. Biol. Med. 45, 146-157.
16. Available at: http://proteinatlas.org/tissue-profile.php?antibody- id51610. Accessed 11 February 2010.
17. RAPID-SCAN™ Gene Expression Panels. Applications Guide, Version 2.3. Origene technologies Inc; Available at:www.origene.com. Accessed 1 March 2009.
18. Eisenberg, S. (1984) High density lipoprotein metabolism. J. Lipid Res. 25, 1017-1058.
19. Mastorikuo, M., Mackness, B., Liu, Y., and Mackness, M. (2008) Glycation of paraoxonase-1 inhibits its activity and impairs the ability of high-density lipoprotein to metabolise membrane lipid hydroperoxides. Diabet. Med. 25, 1049-1055.
20. Silver, D. L., Wang, N., Xiao, X., and Tall, A. R. (2001) High density lipoprotein (HDL) particle uptake mediated by scavenger receptor class B type 1 results in selective sorting of HDL cholesterol from protein and polarised cholesterol secretion. J. Biol. Chem. 276, 25287-25293.
21. Sorenson, R. C., Bisgaier, C. L., Aviram, M., Hsu, C., Billecke, S., and La Du, B. N. (1999) Human serum paraoxonase/arylesterase's retained hydrophobic N-terminal leader sequence associates with HDLs by binding phospholipids: apolipoprotein A-I stabilizes activity. Arterioscler. Thromb. Vasc. Biol. 19, 2214-2225.
22. Horke, S., Witte, I., Wilgenbus, P., Kruger, M., Strand, D., and Forstermann, U. (2007) Paraoxonase-2 reduces oxidative stress in vascular cells and decreases endoplasmic reticulum stress-induced caspase activation. Circulation 115, 2055-2064.
23. Horke, S., Witte, I., Wilgenbus, P., Altenhofer, S., Krueger, M., Li, H., and Forstermann, U. (2010) Protective effect of paraoxonase-2 against ER stress-induced apoptosis is lost upon disturbance of calcium-homeostasis. Biochem. J., 426, 73-83.
24. Aviram, M. and Rosenblat, M. (2004) Paraoxonases 1, 2, and 3, oxidative stress, and macrophage foam cell formation during atherosclerosis development. Free Radic. Biol. Med. 37, 1304-1316.
25. Mochizuki, H., Scherer, S. W., Xi, T., Nickle, D. C., Majer, M., Huizenga, J. J., Tsui, L.-C., and Prochazta, M. (1998) Human PON2 gene at 7q21.3: cloning, multiple mRNA forms and missense polymorphisms in the coding sequence. Gene 213, 149-157.